This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.
Presenter: F. , Figliolini1, ,
Authors: F. Figliolini1, V. Cantaluppi2, M. De Lena1, S. Beltramo1, D. Medica1, L. Biancone2, G.P. Segoloni2, G. Camussi2
P-191 Poster of distinction
Isolation, characterization and pro-angiogenic effect of microvesicles (MVs) derived from purified human pancreatic islets
F. Figliolini1, V. Cantaluppi2, M. De Lena1, S. Beltramo1, D. Medica1, L. Biancone2, G.P. Segoloni2, G. Camussi2
1 Research Center for Experimental Medicine (CeRMS), University of Turin, Turin, Italy; 2 Nephrology, Dialysis and Renal Transplantation Unit, University of Turin, Turin, Italy
Objective: Microvesicles (MVs) are small particles that play a key role in cell-to-cell communication through the transfer of proteins and RNAs. MVs are enriched of microRNAs (miRNAs), small non coding RNAs able to modulate protein transduction. The aims of this study were: 1) isolation and characterization of MVs from purified human islets; 2) evaluation of the biological effects of MVs on islet-derived endothelial cells (IECs).
Methods: MVs were isolated by ultracentrifugation from purified human islets and characterized by electronic microscopy, FACS, western blot, bioanalyzer, RT-PCR for specific islet-associated genes and miRNAs. We evaluated on isolated IECs MV-induced; a) transfer of insulin mRNA/protein; b) proliferation (BrdU); c) resistance to apoptosis (TUNEL); d) angiogenesis on Matrigel.
Results: Islet-derived MVs sized between 0.1-1 ?m and expressed different membrane molecules (integrins, CD44, classI-II HLA). MVs also expressed insulin and C-peptide and shuttled mRNAs involved in insulin secretion and signal transduction (insulin receptor, IRS2, AKT2, PDX1) and several miRNAs, including the beta-cell specific miR-7 and miR-375 and the pro-angiogenic miR-126 and miR-296. MVs were internalized into IECs inducing insulin mRNA/protein expression, cell proliferation, resistance to apoptosis and enhanced angiogenesis. All these effects were significantly decreased by pre-treatment of MVs with 1U/ml RNase, suggesting a key role of RNA transfer from MVs to IECs. In addition, MV-stimulated IECs showed the up-regulation of pro-angiogenic genes and the activation of the P-Akt/Akt pathway.
Conclusions: Human islets release biologically active MVs able to shuttle specific proteins, mRNAs and miRNAs into target cells. MVs exert a pro-angiogenic effect on IECs, suggesting a putative role for islet-derived MVs in beta cell-endothelium cross-talk and in the neoangiogenesis processes of transplanted islets.
/P-191 Poster of distinction
Isolation, characterization and pro-angiogenic effect of microvesicles (MVs) derived from purified human pancreatic islets
F. Figliolini1, V. Cantaluppi2, M. De Lena1, S. Beltramo1, D. Medica1, L. Biancone2, G.P. Segoloni2, G. Camussi2
1 Research Center for Experimental Medicine (CeRMS), University of Turin, Turin, Italy; 2 Nephrology, Dialysis and Renal Transplantation Unit, University of Turin, Turin, Italy
Objective: Microvesicles (MVs) are small particles that play a key role in cell-to-cell communication through the transfer of proteins and RNAs. MVs are enriched of microRNAs (miRNAs), small non coding RNAs able to modulate protein transduction. The aims of this study were: 1) isolation and characterization of MVs from purified human islets; 2) evaluation of the biological effects of MVs on islet-derived endothelial cells (IECs).
Methods: MVs were isolated by ultracentrifugation from purified human islets and characterized by electronic microscopy, FACS, western blot, bioanalyzer, RT-PCR for specific islet-associated genes and miRNAs. We evaluated on isolated IECs MV-induced; a) transfer of insulin mRNA/protein; b) proliferation (BrdU); c) resistance to apoptosis (TUNEL); d) angiogenesis on Matrigel.
Results: Islet-derived MVs sized between 0.1-1 ?m and expressed different membrane molecules (integrins, CD44, classI-II HLA). MVs also expressed insulin and C-peptide and shuttled mRNAs involved in insulin secretion and signal transduction (insulin receptor, IRS2, AKT2, PDX1) and several miRNAs, including the beta-cell specific miR-7 and miR-375 and the pro-angiogenic miR-126 and miR-296. MVs were internalized into IECs inducing insulin mRNA/protein expression, cell proliferation, resistance to apoptosis and enhanced angiogenesis. All these effects were significantly decreased by pre-treatment of MVs with 1U/ml RNase, suggesting a key role of RNA transfer from MVs to IECs. In addition, MV-stimulated IECs showed the up-regulation of pro-angiogenic genes and the activation of the P-Akt/Akt pathway.
Conclusions: Human islets release biologically active MVs able to shuttle specific proteins, mRNAs and miRNAs into target cells. MVs exert a pro-angiogenic effect on IECs, suggesting a putative role for islet-derived MVs in beta cell-endothelium cross-talk and in the neoangiogenesis processes of transplanted islets.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada